GlassScriptPhysician profile
Alidad Arabshahi
NPI 1235200155
$1,326.19
in general payments reported to CMS, 2019-2025
16 companies · $246 in 2025
The $246 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $267 · 2020: $28.36 · 2021: $142 · 2022: $437 · 2023: $190 · 2024: $15.31 · 2025: $246.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $452.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $451.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $454.81 | 2019-2023 | |
| Acclarent, INC | $162.82 | 2019-2022 | |
| Sobi, INC | $138.23 | 2022 | |
| Avadel Cns Pharmaceuticals, LLC | $104.08 | 2025 | Lumryz |
| Glaxosmithkline, LLC. | $99.44 | 2022-2025 | Nucala |
| Alk-Abello, INC | $63.35 | 2022 | |
| Medtronic, INC. | $55.38 | 2023 | Bizact |
| 3b Medical, INC. | $42.21 | 2025 | Luna |
| Harmony Biosciences LLC | $42.02 | 2025 | |
| Kaleo, INC. | $41.79 | 2019-2021 | |
| Inspire Medical Systems, INC. | $31.11 | 2025 | Inspire |
| Stryker Corporation | $21.57 | 2022 | |
| Genzyme Corporation | $19.08 | 2023 | |
| Phadia US INC. | $18.87 | 2019 | |
| Resmed Corp | $16.12 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $15.31 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alidad Arabshahi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.